ConductScience.org, home

Gene · 23600

AMACR: alpha-methylacyl-CoA racemase

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. AMACR: alpha-methylacyl-CoA racemase. Genes, record 23600. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23600

On this page

Gene

Symbol
AMACR
HGNC
Name
alpha-methylacyl-CoA racemase
HGNC
NCBI Gene ID
23600
NCBI Gene
HGNC ID
HGNC:451
HGNC
Ensembl
ENSG00000242110
NCBI Gene
Aliases
AMACRD, CBAS4, P504S, RACE, RM
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9UHK6Alpha-methylacyl-CoA racemase3820Ensembl, GeneID, HGNC

Source UniProt

Patents35

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026067851 A2026-04-21356Q9UHK6Espacenet
JP 2026004568 A2026-01-1437163Q9UHK6Espacenet
EP 4650780 A22025-11-196100Q9UHK6Espacenet
JP 2025517970 A2025-06-126100Q9UHK6Espacenet
JP 2025062604 A2025-04-144320Q9UHK6Espacenet
JP 2023521663 A2023-05-25355Q9UHK6Espacenet
US 11446398 B22022-09-204320Q9UHK6Espacenet
JP 2022524081 A2022-04-27107291Q9UHK6Espacenet
JP 2021530985 A2021-11-18463Q9UHK6Espacenet
WO 2021202604 A12021-10-07356Q9UHK6Espacenet

1 to 10 of 35

See all 35 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants677

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleAMACR papersNewest fiscal year
P30CA008748Cancer Center Support Grant172025
P30CA006973Regional Oncology Research Center122025
P50CA097186The Pacific Northwest Prostate Cancer SPORE82025
U01CA113913Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern82025
P30CA016672Cancer Center Support Grant72025
P50CA092629SPORE in Prostate Cancer72025
P30CA016056Roswell Park Cancer Center Support Grant62025
P30CA072720Cancer Center Support Grant52025
P50CA186786Michigan Prostate SPORE 2025-203052025
R01CA241164Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma42025

1 to 10 of 677Source NIH's project files

See all 677 nih grants

Papers2,301

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Refining prostate cancer diagnosis: correlative analysis of Gleason scores and immunohistochemical markers.Diagn Pathol202642823706PubTator, text miningPubMed
Expanding the clinicopathological spectrum of BAP1 mutated ccRCC: a study of 84 cases in multi-center cohort.Hum Pathol202642822734PubTator, text miningPubMed
Solitary Testicular Metastasis as the Only Site of Recurrence in Prostate Adenocarcinoma.Cureus202642799107PubTator, text miningPubMed
Triple detection of the tumor proteins p63, Ki-67 and Alpha-methylacyl-CoA racemase in the pathological diagnosis of prostate cancer.J Med Biochem202642781326PubTator, text miningPubMed
Histopathological Study of Prostate Core Needle Biopsies in Enugu, Southeast Nigeria and the Role of Immunohistochemistry in Resolving Diagnostic Dilemmas.Niger Med J202642676831PubTator, text miningPubMed
Renal Cell Carcinoma With Hemangioblastoma-Like Features, Fibromyomatous Stroma, and TSC1 Mutation.Case Rep Med202642638884PubTator, text miningPubMed
Kinase Fusions Define a Distinct Subset of BRAF V600E‑Negative Metanephric Adenomas : A Multi-Institutional Study of 7 Cases.Am J Surg Pathol202642638313PubTator, text miningPubMed
Upper tract urothelial carcinoma mimicking emphysematous pyelonephritis: a diagnostic challenge case report.Int J Surg Case Rep202642578240PubTator, text miningPubMed
Clear Cell Carcinoma of the Left Colon: A Case Report.Am J Case Rep202642563356PubTator, text miningPubMed
Papillary Hyperplasia in Autosomal Dominant Polycystic Kidney Disease: A Multi-Institutional Study With Immunohistochemical and Molecular Characterization.Am J Surg Pathol202642548188PubTator, text miningPubMed

1 to 10 of 2,301

See all 2,301 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/23600

GET https://conductscience.org/api/genes/v1/23600/patents?page=2